PATENT CLAIM ANALYSIS

Application Number: 16042031
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "718000"]

Abstract:
The present invention provides methods of administering nitric oxide (NO) to a patient, the method comprising delivering nitric oxide-containing gas directly into arterial or arterialized blood. The methods of the present invention may be used in the treatment or prevention of a variety of diseases and disorders responsive to nitric oxide, including those resulting from ischemia or hypoxia.

Claim (Index 1):
A method of treating a disease, disorder or condition responsive to nitric oxide in a patient in need thereof, comprising:\n oxygenating withdrawn blood through an oxygen permeable membrane of an oxygen transfer unit within an oxygenation compartment of an extracorporeal membrane oxygenation system (ECMO) to produce arterialized blood; administering a therapeutically effective amount of nitric oxide (NO)-containing gas directly into the oxygenated blood of the patient through an NO permeable membrane of an NO transfer unit of a gas transfer unit downstream of the oxygen transfer unit; and infusing the blood produced in step b) into the patient.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.3913
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14402786', '14095621', '10953747', '10384301', '13116219']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6881499726687087
- 35 USC 102 Novelty (BERT): 0.5799828353324588
- Combined Prediction Score: 0.6773332589350837
- Mean Citation Score: 283.736874
- Max Citation Score: 462.03397
- Similarity Product: 426.4266377772302

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test